ArticlePolymers2025
Preparation of Crosslinked Alginate Hydrogels for the Adsorption and Sustainable Release of Doxorubicin Hydrochloride.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since it is expensive and takes considerable time to synthesize a new drug or improve an old one, a drug carrier can be used instead for control and targeted release of the drug. In this study, hydrogel beads were used as drug carriers for the controlled release of doxorubicin hydrochloride. Aiming to incorporate doxorubicin hydrochloride into hydrogel, various metal crosslinked alginate beads were prepared. Doxorubicin hydrochloride was incorporated by adsorption into the beads and studied the factors affecting the adsorption of drug onto the hydrogel beads. The results showed that ferric crosslinked alginate (Fe(III)-Alg) and stannous crosslinked alginate (Sn-Alg) hydrogel beads had a better adsorption percentage which was more than 21%. The amount of hydrogel, time, drug concentration, and pH of the solution all influenced the adsorption percentage. Hence, the adsorption was the best at neutral pH after 24 h when 100 mg of Fe(III)-Alg was added to the drug. Moreover, the release of the drug at different body simulation pH was investigated. The time and pH of the solution influenced the drug release where maximum drug release percentage was 82.822% after 25 h when the solution's pH was 1.52. This system is assumed to follow the Higuchi kinetic release model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.